These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22767606)

  • 1. A generic crystallization-like model that describes the kinetics of amyloid fibril formation.
    Crespo R; Rocha FA; Damas AM; Martins PM
    J Biol Chem; 2012 Aug; 287(36):30585-94. PubMed ID: 22767606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. True and apparent inhibition of amyloid fibril formation.
    Martins PM
    Prion; 2013; 7(2):136-9. PubMed ID: 23232498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of water in protein aggregation and amyloid polymorphism.
    Thirumalai D; Reddy G; Straub JE
    Acc Chem Res; 2012 Jan; 45(1):83-92. PubMed ID: 21761818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth.
    Morris AM; Watzky MA; Agar JN; Finke RG
    Biochemistry; 2008 Feb; 47(8):2413-27. PubMed ID: 18247636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth.
    Watzky MA; Morris AM; Ross ED; Finke RG
    Biochemistry; 2008 Oct; 47(40):10790-800. PubMed ID: 18785757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates.
    Almstedt K; Nyström S; Nilsson KP; Hammarström P
    Prion; 2009; 3(4):224-35. PubMed ID: 19923901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-like fibril formation by polyQ proteins: a critical balance between the polyQ length and the constraints imposed by the host protein.
    Scarafone N; Pain C; Fratamico A; Gaspard G; Yilmaz N; Filée P; Galleni M; Matagne A; Dumoulin M
    PLoS One; 2012; 7(3):e31253. PubMed ID: 22438863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early mechanisms of amyloid fibril nucleation in model and disease-related proteins.
    Morel B; Conejero-Lara F
    Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140264. PubMed ID: 31437584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic Analysis of Amyloid Formation.
    Meisl G; Michaels TCT; Linse S; Knowles TPJ
    Methods Mol Biol; 2018; 1779():181-196. PubMed ID: 29886534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregate geometry in amyloid fibril nucleation.
    Irbäck A; Jónsson SÆ; Linnemann N; Linse B; Wallin S
    Phys Rev Lett; 2013 Feb; 110(5):058101. PubMed ID: 23414048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
    Ghosh P; Kumar A; Datta B; Rangachari V
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a molecular theory of early and late events in monomer to amyloid fibril formation.
    Straub JE; Thirumalai D
    Annu Rev Phys Chem; 2011; 62():437-63. PubMed ID: 21219143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Origin of the Combined Effect of Surfaces and Mechanical Agitation on Amyloid Formation.
    Grigolato F; Colombo C; Ferrari R; Rezabkova L; Arosio P
    ACS Nano; 2017 Nov; 11(11):11358-11367. PubMed ID: 29045787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling amyloid fibril formation kinetics: mechanisms of nucleation and growth.
    Gillam JE; MacPhee CE
    J Phys Condens Matter; 2013 Sep; 25(37):373101. PubMed ID: 23941964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of N-glycosylation site variants during human PrP aggregation and fibril nucleation.
    Mishra R; Elgland M; Begum A; Fyrner T; Konradsson P; Nyström S; Hammarström P
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):909-921. PubMed ID: 30935958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-folding and aggregation of amyloid nanofibrils.
    Paparcone R; Cranford SW; Buehler MJ
    Nanoscale; 2011 Apr; 3(4):1748-55. PubMed ID: 21347488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.